[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100355499":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":20,"locations":30,"responsibleParty":49,"collaborators":19,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":19,"eligibilityCriteria":57,"healthyVolunteers":58,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":19,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":19,"overallStatus":33,"whyStopped":19,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"University of New Mexico","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Single-arm cohort","Baseline experimental measurements will be collected for each individual participant twice prior to zinc supplementation (0 month and 3 month time points). After zinc supplementation, experimental measurements will be collected for each individual participant at the 6 month and 9 month time points. The zinc intervention is zinc picolinate 15 mg once per day for 6 months.",[12],"Drug: Zinc Picolinate 15 Mg",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DRUG","Zinc Picolinate 15 Mg","zinc picolinate, 15 mg\u002Fday for 6 months",[9],null,[21,26],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Laurie G Hudson, PhD","CONTACT","505-272-2482","lhudson@salud.unm.edu",{"name":27,"role":23,"phone":28,"phoneExt":19,"email":29},"Debra MacKenzie, PhD","505-272-6535","dmackenzie@salud.unm.edu",[31],{"facility":32,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"University of New Mexico Health Sciences Center","RECRUITING","Albuquerque","New Mexico","87131","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-106.65114,35.08449,{"lat":43,"lon":42},[46,47],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},{"name":27,"role":23,"phone":28,"phoneExt":19,"email":48},"DMacKenzie@salud.unm.edu",{"type":50,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100355499","phase-2-thinking-zinc-a-study-of-zinc-supplements-on-the-navajo-nation-100355499",false,"NCT03908736","Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation","Thinking Zinc: A Study of Zinc Supplementation to Ameliorate Adverse Effects of Mine Waste Exposure on the Navajo Nation","Inclusion Criteria:\n\n* Men or women between the ages of 21 and 64 years of age\n* Lives in or near the participating communities of Blue Gap-Tachee Arizona or Red Water Pond Road Community New Mexico\n* Willing to provide blood and urine samples\n* Willing to attend study visits on scheduled dates\n* Willing to take a daily zinc supplement\n\nExclusion Criteria:\n\n* Women who are pregnant or nursing or women who plan to become pregnant during the course of the study.\n* Individuals who have self-reported diabetes, report that they are undergoing treatment for diabetes, or are currently taking medication for diabetes.\n* Known or suspected allergy to zinc.\n* Individuals previously diagnosed with syndromes of copper homeostasis (Menkes disease or Wilsons disease).\n* Individuals consuming zinc supplements or multivitamins and are unwilling to stop for the duration of the study.",true,"ALL","21 Years","64 Years",{"count":63,"type":64},100,"ESTIMATED","INTERVENTIONAL",[67],"PHASE2","This is a study to assess the effect of dietary zinc supplementation to mitigate biomarkers of metal toxicity in exposed tribal populations.",[70,71],"DNA Damage","Immune System Disorder","2026-06-02",{"date":74,"type":75},"2026-06-04","ACTUAL",{"date":77,"type":75},"2019-05-19",{"date":79,"type":64},"2027-12",{"name":5,"class":6},1]